Bioniz Therapeutics to Present at Evercore ISI 4th Annual HealthCONx Conference

IRVINE, Calif.: IRVINE, Calif., Nov. 9, 2021 /PRNewswire/ -- Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company developing precision cytokine targeted therapies to treat immuno-inflammatory diseases, today announced that management will participate in a fireside chat at the upcoming Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1, 2021,...

Click to view original post